Bisphosphonate-induced Atypical Femoral Shaft Fracture
نویسندگان
چکیده
منابع مشابه
Bisphosphonate use and atypical fractures of the femoral shaft.
BACKGROUND Studies show conflicting results regarding the possible excess risk of atypical fractures of the femoral shaft associated with bisphosphonate use. METHODS In Sweden, 12,777 women 55 years of age or older sustained a fracture of the femur in 2008. We reviewed radiographs of 1234 of the 1271 women who had a subtrochanteric or shaft fracture and identified 59 patients with atypical fr...
متن کاملRisk of atypical femoral fracture during and after bisphosphonate use
BACKGROUND AND PURPOSE Use of bisphosphonates in women is associated with higher risk of atypical femoral fractures. The risk in terms of timing of use and type of bisphosphonate, and in men, remains unclear. PATIENTS AND METHODS We reviewed radiographs of 5,342 Swedish women and men aged 55 years or more who had had a fracture of the femoral shaft in the 3-year period 2008-2010 (97% of those...
متن کاملAtypical femoral fractures and bisphosphonate use.
Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cush1. ing’s syndrome. Lancet 2006;367:1605-17. de Bruin C, Pereira AM, Feelders RA, et al. Coexpression of 2. dopamine and somatostatin receptor subtypes in corticotroph adenomas. J Clin Endocrinol Metab 2009;94:1118-24. Schmid HA. Pasireotide (SOM230): development, mecha3. nism of action and potential applications. Mol Cell Endocrinol 2008;2...
متن کاملBisphosphonate-associated Atypical Fractures that are not “Atypical Femoral Fractures”
Aims: Responding to the steadily increasing number of unusual subtrochanteric and mid-shaft femoral (ST/FS) fractures in persons treated with the bisphosphonate drugs since the index cases were described in 2003, the American Society of Bone and Mineral Research (ASBMR) convened a committee tasked with finding a precise definition. Their present definition, a composite from two publications, in...
متن کاملBisphosphonate-associated atypical subtrochanteric femur fracture.
Bisphosphonates help prevent progressive bone mineralization loss and subsequent osteoporotic fractures. However, long-term bisphosphonate therapy paradoxically increases the risk of a unique injury called an atypical subtrochanteric femur fracture. Despite this, the benefits of bisphosphonates outweigh the risks, because far more pathologic fractures are prevented than induced. The early ident...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cureus
سال: 2017
ISSN: 2168-8184
DOI: 10.7759/cureus.1750